The Valley Desk

NCT03989206 · Interventional trial

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Overall registry status Completed

Phase 3

Conditions Moderate-to-Severe Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov